 <h1>Bumetanide Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of bumetanide include:</b> hypokalemia and hyperuricemia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to bumetanide: oral tablet</i></p><p>Other dosage forms:</p><ul><li>injection solution</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Bumetanide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required, and dose and dosage schedule have to be adjusted to the individual patient's needs.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, bumetanide may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking bumetanide:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal pain</li>
<li>blurred vision</li>
<li>confusion</li>
<li>decreased urine output</li>
<li>dizziness</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>fast or irregular heartbeat</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>irritability</li>
<li>joint pain, stiffness, or swelling</li>
<li>loss of appetite</li>
<li>loss of mental alertness</li>
<li>lower back, side, or stomach pain</li>
<li>mood or mental changes</li>
<li>muscle pain or cramps</li>
<li>nausea or vomiting</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>shortness of breath</li>
<li>sweating</li>
<li>swelling of face, hands, feet, ankles, or lower legs</li>
<li>troubled breathing</li>
<li>unexplained weight loss</li>
<li>unusual tiredness or weakness</li>
<li>weak pulse</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Agitation</li>
<li>back pain</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>chest pain</li>
<li>convulsions (seizures)</li>
<li>deep or fast breathing with dizziness</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly</li>
<li>fever</li>
<li>hallucinations</li>
<li>hives</li>
<li>increase in heart rate</li>
<li>increased blood pressure</li>
<li>numbness of feet, hands, and around the mouth</li>
<li>pinpoint red spots on the skin</li>
<li>rapid breathing</li>
<li>stiff neck</li>
<li>sunken eyes</li>
<li>trembling, jerking of hands</li>
<li>unusual bleeding or bruising</li>
<li>weight gain</li>
<li>wrinkled skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking bumetanide:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Difficulty breathing</li>
<li>pain in chest, groin, or legs, especially the calves</li>
<li>severe, sudden headache</li>
<li>slurred speech</li>
<li>sudden loss of coordination</li>
<li>sudden, severe weakness or numbness in the arm or leg</li>
<li>sudden, unexplained shortness of breath</li>
<li>unusual drowsiness, dullness, or feeling of sluggishness</li>
<li>vision changes</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of bumetanide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Rare</i>
</p><ul>
<li>Decreased interest in sexual intercourse</li>
<li>diarrhea</li>
<li>difficulty with moving</li>
<li>ear discomfort</li>
<li>feeling of constant movement of self or surroundings</li>
<li>inability to have or keep an erection</li>
<li>itching skin</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>muscle or bone pain</li>
<li>muscle stiffness</li>
<li>nipple tenderness</li>
<li>pain, swelling, or redness in joints</li>
<li>rash</li>
<li>sensation of spinning</li>
<li>shorter than usual time to ejaculation of semen</li>
<li>trouble with hearing</li>
<li>upset stomach</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bumetanide: compounding powder, injectable solution, oral tablet</i></p><h3>Metabolic</h3><p>Besides acting on the loop of Henle, bumetanide also inhibits phosphate reabsorption in the proximal tubule, resulting in phosphaturia.  Since phosphorous is abundant in most diets, bumetanide-induced phosphaturia may not be significant except in malnourished patients, patients on life support, and patients with significant muscle weakness.</p>
<p></p>
<p>Calcium balance appears to remain neutral during treatment with a loop diuretic (i.e., furosemide, bumetanide).  Although loop diuretics cause an increase in renal calcium excretion, this appears to be compensated for by a parathyroid-dependent increase in 1,25-dihydroxyvitamin D levels, which increases intestinal calcium absorption.  Bone metabolism does not appear to be significantly affected by loop diuretics.<sup>[Ref]</sup></p><p>Metabolic side effects associated with bumetanide, as with other loop diuretics, occur in 7% to 20% of patients, and include hyponatremia, hypokalemia, hypochloremia, and hyperuricemia.  These side effects may be more likely in patients with renal insufficiency.  Glucose intolerance is reported in up to 14% of elderly patients.  Hypokalemia may lead to increased renal tubular bicarbonate reabsorption, resulting in metabolic alkalosis.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Musculoskeletal side effects have included muscle cramps in 1.1% and weakness in 0.2% of patients.<sup>[Ref]</sup></p><h3>Renal</h3><p>Renal insufficiency, manifested as a rise in serum creatinine and BUN, may occur in up to 7% of patients.  It is usually due to extracellular fluid volume depletion and is readily reversible.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cardiovascular side effects include hypotension in less than 2% of patients.  Patients with a history of cardiac arrhythmias should be monitored closely because of the risk of hypokalemia.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects were reported in less than 2% of patients and included nausea, vomiting, loose stools, and constipation.  There have been rare reports of hyperamylasemia and pancreatitis associated with bumetanide use.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects, such as headache, dizziness, deafness, tinnitus, vertigo, and decreased hearing, are reported in less than 2% of patients.  Encephalopathy after bumetanide administration is reported in patients with severe liver disease.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity reactions are rare.  Rash is reported in less than 1% of treated patients.  Because cross-reactivity with furosemide is rare, bumetanide can be substituted at about a 1:40 dose ratio of bumetanide to furosemide in patients allergic to furosemide.<sup>[Ref]</sup></p><p>Severe hypersensitivity reactions such as Stevens-Johnson syndrome and recurrent urticaria have been reported in rare cases.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Dermatologic side effects have included pseudoporphyria, Stevens-Johnson syndrome, and toxic epidermal necrolysis.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hematologic side effects are extremely rare.  Cases of thrombocytopenia, mild anemia, and leukopenia have been reported.<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Ring-Larsen H "Bumetanide in the treatment of hepatic ascites. A short and long-term study." Acta Med Scand 195 (1974): 411-4</p><p id="ref_2">2. Menday AP, Adnitt PI, Underwood PN "Effect of long-term treatment with bumetanide/amiloride on electrolytes and renal function in elderly patients with heart failure." Curr Ther Res Clin Exp 50 (1991): 57-64</p><p id="ref_3">3. Kubik MM, Bowers E, Underwood PN "Longterm experience of the routine use of bumetanide." Br J Clin Pract 30 (1976): 11-4</p><p id="ref_4">4. Ward A, Heel RC "Bumetanide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use." Drugs 28 (1984): 426-64</p><p id="ref_5">5. Rejnmark L,  Vestergaard P,  Heickendorff L,  Andreasen F,  Mosekilde L "Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study." J Intern Med 250 (2001): 144-53</p><p id="ref_6">6. Hofstetter A "Bumetanide, a new diuretic." Int Urol Nephrol 6 (1974): 35-42</p><p id="ref_7">7. Chaudhuri ML, Catania J "A comparison of the effects of bumetanide (Burinex) and frusemide on carbohydrate metabolism in the elderly." Br J Clin Pract 42 (1988): 427-9</p><p id="ref_8">8. Rejnmark L,  Vestergaard P,  Heickendorff L,  Andreasen F,  Mosekilde L "Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover." J Intern Med 257 (2005): 176-84</p><p id="ref_9">9. Johnson CA, Grant KL, Madalon MG "Severe musculoskeletal syndrome in patients with renal failure and hypoalbuminemia receiving bumetanide." Clin Pharm 6 (1987): 735-41</p><p id="ref_10">10. Berg KJ, Tromsdal A, Wideroe TE "Diuretic action of bumetanide in advanced chronic renal insufficiency." Eur J Clin Pharmacol 9 (1976): 265-75</p><p id="ref_11">11. "Product Information. Bumex (bumetanide)." Roche Laboratories, Nutley, NJ. </p><p id="ref_12">12. Dixon DW, Barwolf-Gohlke C, Gunnar RM "Comparative efficacy and safety of bumetanide and furosemide in long- term treatment of edema due to congestive heart failure." J Clin Pharmacol 21 (1981): 680-7</p><p id="ref_13">13. Lynggaard F, Bjorndal N "Bumetanide-induced hyperamylaseaemia in patients with renal insufficiency." Lancet 2 (1977): 1355</p><p id="ref_14">14. Stenvinkel P, Alvestrand A "Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency." Acta Med Scand 224 (1988): 89-91</p><p id="ref_15">15. Handler B, Dhingra RC, Rosen KM "Bumetanide: a new diuretic. Results of clinical efficacy and safety in patients with congestive heart failure." J Clin Pharmacol 21 (1981): 691-6</p><p id="ref_16">16. Leitao EA, Person JR "Bumetanide-induced pseudoporphyria." J Am Acad Dermatol 23 (1990): 129-30</p></div>
<div class="more-resources" id="moreResources">
<h2>More about bumetanide</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>13 Reviews</li>
<li>Drug class: loop diuretics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Bumetanide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Bumetanide Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Bumex</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Edema</li>
<li>Pulmonary Edema</li>
<li>Autism</li>
<li>Ascites</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bumetanide: compounding powder, injectable solution, oral tablet</i></p><h3>Metabolic</h3><p>Besides acting on the loop of Henle, bumetanide also inhibits phosphate reabsorption in the proximal tubule, resulting in phosphaturia.  Since phosphorous is abundant in most diets, bumetanide-induced phosphaturia may not be significant except in malnourished patients, patients on life support, and patients with significant muscle weakness.</p><p></p><p>Calcium balance appears to remain neutral during treatment with a loop diuretic (i.e., furosemide, bumetanide).  Although loop diuretics cause an increase in renal calcium excretion, this appears to be compensated for by a parathyroid-dependent increase in 1,25-dihydroxyvitamin D levels, which increases intestinal calcium absorption.  Bone metabolism does not appear to be significantly affected by loop diuretics.<sup>[Ref]</sup></p><p>Metabolic side effects associated with bumetanide, as with other loop diuretics, occur in 7% to 20% of patients, and include hyponatremia, hypokalemia, hypochloremia, and hyperuricemia.  These side effects may be more likely in patients with renal insufficiency.  Glucose intolerance is reported in up to 14% of elderly patients.  Hypokalemia may lead to increased renal tubular bicarbonate reabsorption, resulting in metabolic alkalosis.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Musculoskeletal side effects have included muscle cramps in 1.1% and weakness in 0.2% of patients.<sup>[Ref]</sup></p><h3>Renal</h3><p>Renal insufficiency, manifested as a rise in serum creatinine and BUN, may occur in up to 7% of patients.  It is usually due to extracellular fluid volume depletion and is readily reversible.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cardiovascular side effects include hypotension in less than 2% of patients.  Patients with a history of cardiac arrhythmias should be monitored closely because of the risk of hypokalemia.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects were reported in less than 2% of patients and included nausea, vomiting, loose stools, and constipation.  There have been rare reports of hyperamylasemia and pancreatitis associated with bumetanide use.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects, such as headache, dizziness, deafness, tinnitus, vertigo, and decreased hearing, are reported in less than 2% of patients.  Encephalopathy after bumetanide administration is reported in patients with severe liver disease.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity reactions are rare.  Rash is reported in less than 1% of treated patients.  Because cross-reactivity with furosemide is rare, bumetanide can be substituted at about a 1:40 dose ratio of bumetanide to furosemide in patients allergic to furosemide.<sup>[Ref]</sup></p><p>Severe hypersensitivity reactions such as Stevens-Johnson syndrome and recurrent urticaria have been reported in rare cases.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Dermatologic side effects have included pseudoporphyria, Stevens-Johnson syndrome, and toxic epidermal necrolysis.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hematologic side effects are extremely rare.  Cases of thrombocytopenia, mild anemia, and leukopenia have been reported.<sup>[Ref]</sup></p><p id="ref_1">1. Ring-Larsen H "Bumetanide in the treatment of hepatic ascites. A short and long-term study." Acta Med Scand 195 (1974): 411-4</p><p id="ref_2">2. Menday AP, Adnitt PI, Underwood PN "Effect of long-term treatment with bumetanide/amiloride on electrolytes and renal function in elderly patients with heart failure." Curr Ther Res Clin Exp 50 (1991): 57-64</p><p id="ref_3">3. Kubik MM, Bowers E, Underwood PN "Longterm experience of the routine use of bumetanide." Br J Clin Pract 30 (1976): 11-4</p><p id="ref_4">4. Ward A, Heel RC "Bumetanide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use." Drugs 28 (1984): 426-64</p><p id="ref_5">5. Rejnmark L,  Vestergaard P,  Heickendorff L,  Andreasen F,  Mosekilde L "Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study." J Intern Med 250 (2001): 144-53</p><p id="ref_6">6. Hofstetter A "Bumetanide, a new diuretic." Int Urol Nephrol 6 (1974): 35-42</p><p id="ref_7">7. Chaudhuri ML, Catania J "A comparison of the effects of bumetanide (Burinex) and frusemide on carbohydrate metabolism in the elderly." Br J Clin Pract 42 (1988): 427-9</p><p id="ref_8">8. Rejnmark L,  Vestergaard P,  Heickendorff L,  Andreasen F,  Mosekilde L "Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover." J Intern Med 257 (2005): 176-84</p><p id="ref_9">9. Johnson CA, Grant KL, Madalon MG "Severe musculoskeletal syndrome in patients with renal failure and hypoalbuminemia receiving bumetanide." Clin Pharm 6 (1987): 735-41</p><p id="ref_10">10. Berg KJ, Tromsdal A, Wideroe TE "Diuretic action of bumetanide in advanced chronic renal insufficiency." Eur J Clin Pharmacol 9 (1976): 265-75</p><p id="ref_11">11. "Product Information. Bumex (bumetanide)." Roche Laboratories, Nutley, NJ. </p><p id="ref_12">12. Dixon DW, Barwolf-Gohlke C, Gunnar RM "Comparative efficacy and safety of bumetanide and furosemide in long- term treatment of edema due to congestive heart failure." J Clin Pharmacol 21 (1981): 680-7</p><p id="ref_13">13. Lynggaard F, Bjorndal N "Bumetanide-induced hyperamylaseaemia in patients with renal insufficiency." Lancet 2 (1977): 1355</p><p id="ref_14">14. Stenvinkel P, Alvestrand A "Loop diuretic-induced pancreatitis with rechallenge in a patient with malignant hypertension and renal insufficiency." Acta Med Scand 224 (1988): 89-91</p><p id="ref_15">15. Handler B, Dhingra RC, Rosen KM "Bumetanide: a new diuretic. Results of clinical efficacy and safety in patients with congestive heart failure." J Clin Pharmacol 21 (1981): 691-6</p><p id="ref_16">16. Leitao EA, Person JR "Bumetanide-induced pseudoporphyria." J Am Acad Dermatol 23 (1990): 129-30</p><h2>More about bumetanide</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>13 Reviews</li>
<li>Drug class: loop diuretics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Bumetanide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Bumetanide Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Edema</li>
<li>Pulmonary Edema</li>
<li>Autism</li>
<li>Ascites</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>